|A 3 Year Study to Evaluate the Safety and Efficacy of Low Dose Ladostigil in Patients With Mild Cognitive Impairment||
||210||All||55 Years to 85 Years (Adult, Senior)||NCT01429623||CO17730
|February 2012||July 2016||September 2016||September 7, 2011||June 15, 2017||June 15, 2017||
|2||NCT00000173||Completed||Memory Impairment Study (Mild Cognitive Impairment Study)||
||NIH / Other||
||All||55 Years to 90 Years (Adult, Senior)||NCT00000173||IA0011
|March 1999||January 2004||January 2004||November 1, 1999||December 11, 2009||
† Study has passed its completion date and status has not been verified in more than two years.